A novel fusion protein of IP10-scFv retains antibody specificity and chemokine function

Biochemical and Biophysical Research Communications

Volumn 320, Issue 2, 2004, Pages 506-513

  Guo, Jun Qing ^a   Chen, Liu ^b   Ai, Hong Wu ^c   Jing, Jian Nian ^c   Zhou, Ji Yong ^a   Zhang, Chu Yu ^b   You, Shang You ^c  

^a ZHEJIANG UNIVERSITY   (China)

^b WUHAN UNIVERSITY   (China)

^c Wuhan Children's Hospital   (China)

Author keywords

Acidic isoferritin; Antibody chemokine fusion protein; Hepatoma; Immunotherapy; Interferon inducible protein 10; Single chain Fv fragment

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HYBRID PROTEIN; ISOFERRITIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; BINDING AFFINITY; CELL SURFACE; CHEMOTAXIS; CONTROLLED STUDY; EFFECTOR CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; MYELOMA CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; T LYMPHOCYTE;

ANIMALS; ANTIBODY SPECIFICITY; BASE SEQUENCE; CELL LINE; DNA PRIMERS; GENETIC VECTORS; IMMUNOGLOBULIN FRAGMENTS; MICE; PROTEIN BINDING; RECEPTORS, CYTOKINE; RECOMBINANT FUSION PROTEINS; T-LYMPHOCYTES;

MURINAE;

EID: 2942748287     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2004.05.193     Document Type: Article

References (36)

1. Rossi D., Zlotnik A. The biology of chemokines and their receptors. Annu. Rev. Immunol. 18:2000;217-242
2. Cascieri M.A., Springer M.S. The chemokine/chemokine-receptor family: potential and progress for therapeutic intervention. Curr. Opin. Chem. Biol. 4:2000;420-427
3. Zlotnik A., Yoshie O. Chemokines: a new classification system and their role in immunity. Immunity. 12:2000;121-127
4. Luster A.D. Chemokines - chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:1998;436-445
5. Farber J.M. Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukoc. Biol. 61:1997;246-257
6. Loetscher M., Gerber B., Loetscher P., Jones S.A., Piali L., Clark-Lewis I., Baggiolini M., Moser B. Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated T-lymphocyte. J. Exp. Med. 184:1996;963-969
7. Luster A.D., Leder P. IP-10, a -C-X-C- chemokine, elicits a potent thymus-dependent antitumor response in vivo. J. Exp. Med. 178:1993;1057-1065
8. Pertl U., Luster A.D., Varki N.M., Homann D., Gaedicke G., Reisfeld R.A., Lode H.N. IFN-γ-inducible protein-10 is essential for the generation of a protective tumor-specific CD8 T cell response induced by single-chain IL-12 gene therapy. J. Immunol. 166:2001;6944-6951
9. Biragyn A., Tani K., Grimm M.C., Weeks S., Kwak L.W. Genetic fusion of chemokines to a self tumor antigen induces protective, T-cell dependent antitumor immunity. Nat. Biotechnol. 17:1999;253-258
10. Angiolillo A.L., Sgadari C., Taub D.D., Liao F., Farber J.M., Maheshwari S., Kleinman H.K., Reaman G.H., Tosato G. Human interferon-inducible protein 10 is a potent inhibitor of angiogenesis in vivo. J. Exp. Med. 182:1995;155-162
11. Arenberg D.A., White E.S., Burdick M.D., Strom S.R., Strieter R.M. Improved survival in tumor-bearing SCID mice treated with interferon-gamma- inducible protein 10 (IP-10/CXCL10). Cancer Immunol. Immunother. 50:2001;533-538
12. Sgadari C., Angiolillo A.L., Cherney B.W., Pike S.E., Farber J.M., Koniaris L.G., Vanguri P., Burd P.R., Sheikh N., Gupta G., Teruya-Feldstein J., Tosato G. Interferon-inducible protein-10 identified as a mediator of tumor necrosis in vivo. Proc. Natl. Acad. Sci. USA. 93:1996;13791-13796
13. Luster A.D., Greenberg S.M., Leder P. The IP-10 chemokine binds to a specific cell surface heparin sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J. Exp. Med. 182:1995;219-231
14. Grazi G.L., Mazziotti A., Legnani C., Jovine E., Miniero R., Gallucci A., Palareti G., Gozzetti G. The role of tumor markers in the diagnosis of hepatocellular carcinoma, with special reference to the des-γ-carboxy prothrombin. Liver Transpl. Surg. 1:1995;249-255
15. You S.Y., Zhang C.Y., Yi X.P., Huang W. Evaluation of clinical significance of isoferritin by development of new monoclonal antibodies specific for acidic isoferritin. Hybridoma. 20:2001;243-248
16. Vanguri P., Farber J.M. Identification of CRG-2. An interferon-inducible mRNA predicted to encode a murine monokine. J. Biol. Chem. 265:1990;15049-15057
17. Guo J.Q., You S.Y., Li L., Zhang Y.Z., Huang J.N., Zhang C.Y. Construction and high-level expression of a single-chain Fv antibody fragment specific for acidic isoferritin in Escherichia coli. J. Biotechnol. 102:2003;177-189
18. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 7:1976;248-254
19. Zhu H.F., Wang X.L., Shen G.X., Zhang Y., You S.Y., Huang W. Preparation and characterization of monoclonal antibodies against placental acidic ferritin. J. Monoclonal Antibody. 11:1995;39-41
20. Friguet B., Chaffotte A.F., Djavadi-Ohaniance L., Goldberg M.E. Measurements of the true affinity constant in solution of antigen-antibody complexes by enzyme-linked immunosorbent assay. J. Immunol. Methods. 77:1985;305-319
21. Falk W., Goodwin R.H., Leonard E.J. A 48-well micro chemotaxis assembly for rapid and accurate measurement of leukocyte migration. J. Immunol. Methods. 33:1980;239-247
22. Rosenberg S.A., Yang J.C., White D.E., Steinberg S.M. Durability of complete responses in patients with metastatic cancer treated with high-dose interleukin-2: identification of the antigens mediating response. Ann. Surg. 228:1998;307-319
23. Ruef C., Coleman D.L. Granulocyte-macrophage colony-stimulating factor: pleiotropic cytokine with potential clinical usefulness. Rev. Infect. Dis. 12:1990;41-62
24. Tsung K., Meko J.B., Peplinski G.R., Tsung Y.L., Norton J.A. IL-12 induces T helper 1-directed antitumor response. J. Immunol. 158:1997;3359-3365
25. Motzer R.J., Rakhit A., Schwartz L.H., Olencki T., Malone T.M., Sandstrom K., Nadeau R., Parmar H., Bukowski R. Phase I trail of subcutaneous recombinant human interleukin-12 in patients with advanced renal cell carcinoma. Clin. Cancer Res. 4:1998;1183-1191
26. Gillies S.D., Reilly E.B., Lo K.M., Reisfeld R.A. Antibody-targeted interleukin-2 stimulates T-cell killing of autologous tumor cells. Proc. Natl. Acad. Sci. USA. 89:1992;1428-1432
27. Penichet M.L., Harvill E.T., Morrison S.L. An IgG3-IL-2 fusion protein recognizing a murine B cell lymphoma exhibits effective tumor imaging and antitumor activity. J. Interferon Cytokine Res. 18:1998;597-607
28. Hornick J.L., Khawli L.A., Hu P., Lynch M., Anderson P.M., Epstein A.L. Chimeric CLL-1 antibody fusion proteins containing granulocyte-macrophage colony-stimulating factor or interleukin-2 with specificity for B-cell malignancies exhibit enhanced effector functions while retaining tumor targeting properties. Blood. 89:1997;4437-4447
29. Li J., Hu P., Khawli L.A., Epstein A.L. LEC/chTNT-3 fusion protein for the immunotherapy of experimental solid tumors. J. Immunother. 26:2003;320-331
30. Li J., Hu P., Khawli L.A., Epstein A.L. Complete regression of experimental solid tumors by combination LEC/chTNT-3 immunotherapy and CD25(+) T-cell depletion. Cancer Res. 63:2003;8384-8392
31. Yokota T., Milenic D.E., Whitlow M., Schlom J. Rapid tumor penetration of a single-chain Fv and comparison with other immunoglobulin forms. Cancer Res. 52:1992;3402-3408
32. Kanegane C., Sgadari C., Kanegane H., Teruya-Feldstein J., Yao L., Gupta G., Farber J.M., Liao F., Liu L., Tosato G. Contribution of the CXC chemokines IP-10 and Mig to the antitumor effects of IL-12. J. Leukoc. Biol. 64:1998;384-392
33. Tannenbaum C.S., Tubbs R., Armstrong D., Finke J.H., Bukowski R.M., Hamilton T.A. The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. J. Immunol. 161:1998;927-932
34. Angiolillo A.L., Sgadari C., Tosato G. A role for the interferon-inducible protein 10 in inhibition of angiogenesis by interleukin-12. Ann. N. Y. Acad. Sci. 795:1996;158-167
35. Narvaiza I., Mazzolini G., Barajas M., Duarte M., Zaratiegui M., Qian C., Melero I., Prieto J. Intratumoral coinjection of two adenoviruses, one encoding the chemokine IFN-γ-inducible protein-10 and another encoding IL-12, results in marked antitumoral synergy. J. Immunol. 164:2000;3112-3122
36. Palmer K., Hitt M., Emtage P.C., Gyorffy S., Gauldie J. Combined CXC chemokine and interleukin-12 gene transfer enhances antitumor immunity. Gene Ther. 8:2001;282-290